Purchase Order 75N91023P00658
Award Date 9/1/23
Potential Completion Date 8/31/24
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price purchase order contract was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Sentieon, Inc. for $18,000.00. Sentieon, Inc. is a self-certified small disadvantaged business that develops and supplies bioinformatics secondary analysis tools for processing genomics data. The contract is for the provision of Sentieon's proprietary software and licenses to support whole genome sequencing efforts at the National...
- This firm fixed price definitive contract was awarded by the National Institutes of Health National Cancer Institute to Senti Biosciences, Inc., a self-certified small disadvantaged business, for $1,999,993. The contract addresses Topic 414 from the fiscal year 2021 Small Business Innovation Research Program solicitation issued by the Department of Health and Human Services, which sought proposals for synthetic biology gene circuits for cancer therapy. The place of performance is South San...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $3 million firm fixed price purchase order to 10X Genomics, Inc. for genomics products and services. As the prime contractor, 10X Genomics will deliver its genome sequencing platforms and assays to support the agency's cancer research efforts from its Pleasanton, California location through the end of 2023. No subcontractors or set aside designations were indicated. This award draws on...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,102.75 firm fixed price contract to 10X Genomics, Inc. for single cell RNA sequencing on provided RNA samples. 10X Genomics will perform the requested 5' prime single cell RNA sequencing services at their Pleasanton, California facility between February 2nd and 28th, 2023. The National Cancer Institute seeks to advance cancer research and this contract will provide genomic analysis...
- The National Cancer Institute (NCI) awarded a $142,009.29 firm fixed-price purchase order contract to Fundacio Centre De Regulacio Genomica, a non-profit biomedical research institute, to perform targeted gene sequencing on samples collected by NCI's Division of Cancer Epidemiology and Genetics. This contract, which does not have a set-aside designation, is expected to be completed by June 2023. The contract was awarded in September 2021 under simplified acquisition procedures for commercial...
- This firm fixed price contract for $455,000 was awarded by the National Institutes of Health National Cancer Institute to Nvigen Inc. of San Jose, California. The contract is for research under SBIR Phase II topic 403 to develop highly accurate single cell sequencing technologies with spatial resolution capabilities for cancer research applications. The work directly responds to the solicitation seeking proposals in cancer imaging, spatial sequencing, intra-tumor sensing, and other related...
- The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $395,850 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The contract calls for Illumina to provide two Illumina NextSeq2000 Next Generation Benchtop High-Throughput Sequencing Instruments or equivalent equipment to support genomic research at NCI facilities. The solicitation sought quotes for the sequencing instruments to...
- This firm fixed price BPA Call order from the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, is valued at twenty-four thousand eight hundred fifty-seven dollars and eighty-four cents ($24,857.84). Prime contractor 10X Genomics, Inc. will provide single cell kits to the Chen Lab members at its Pleasanton, California location for use in single-cell analysis and research from November 16, 2022 through December 15, 2022. ...
- Nanostring Technologies, Inc. has been awarded a $49,500 purchase order by the National Cancer Institute (NCI), a component of the Department of Health and Human Services' National Institutes of Health (HHS-NIH), to provide an upgrade to geomagnetic data signal processing (GEOMX DSP) software. The firm fixed price contract runs from September 2022 through March 2024 and will be performed in Potomac, Maryland. As the prime contractor, Nanostring will deliver upgraded software to support NCI's...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $15,000 purchase order to 10X Genomics, Inc. for service agreement work. 10X Genomics will perform the services at its Pleasanton, California location from September 2023 through September 2024 under a firm fixed price contract. No additional details were provided on the scope of work requested under the solicitation. The National Cancer Institute supports research to advance cancer...